-
FDA approves Novartis antibacterial treatment for cystic fibrosis
EAST HANOVER, N.J. — The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.
Swiss drug maker Novartis announced the approval of Tobi Podhaler (tobramycin inhalation powder) for managing cystic fibrosis patients with Pseudomonas aeruginosa, or Pa bacteria, in the lungs.
-
Hawaiian Punch says Aloha to the breakfast table
PLANO, Texas — Dr Pepper Snapple Group announced today the new Hawaiian Punch Aloha Morning line of juice drinks to hit store shelves.
The new Aloha Morning line provides a good source of vitamins A, C and E, and each variety contains 40% less sugar than other juice drinks. Hawaiian Punch Aloha Morning comes in three flavors: orange citrus, mixed berry citrus and strawberry citrus.